Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

sleep · Mechanism Report

Can caffeine delay sleep onset and reduce deep sleep, with CYP1A2 rs762551 AC possibly prolonging exposure?

Caffeine can delay sleep onset, reduce deep sleep, and increase sleep fragmentation, while CYP1A2 rs762551 AC may be associated with slower caffeine clearance but is not reliable alone for predicting exposure.

PlausibleOctober 2, 202613 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Caffeine blocks adenosine signaling and can delay sleep onset and reduce deep sleep, while CYP1A2 rs762551 AC is associated with intermediate caffeine clearance that may prolong exposure.

laying out figure…
2 of 6 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim describes caffeine as blocking adenosine signaling, which fits with the established sleep effects of later or higher-dose intake. The graph also frames rs762551 AC as a possible contributor to intermediate clearance and longer exposure, but not as a validated standalone predictor of how long caffeine persists.

Verified conclusion

Caffeine’s sleep effects are well established, whereas using CYP1A2 rs762551 AC alone to predict an individual’s caffeine persistence is less certain.

Clinical sleep effects

  • In a 2025 meta-analysis of 22 controlled crossover trials (956 healthy adults), caffeine increased sleep-onset latency by 8.35 minutes versus placebo and reduced slow-wave sleep—the objective correlate of deep sleep—by 1.01 percentage points.
  • Effects depend substantially on dose and timing. In randomized double-blind crossover evidence, 400 mg delayed sleep onset when taken within 12 hours of bedtime and reduced slow-wave sleep when taken at bedtime or 6 hours before bed. In that study, 100 mg did not significantly affect sleep at the intervals tested.
  • Caffeine can also increase sleep fragmentation, particularly when 400 mg is consumed within 8 hours of bedtime.

Mechanism

  • At usual dietary exposures, caffeine competitively antagonizes adenosine A₁ and A₂A receptors. Adenosine signaling normally contributes to the accumulation of sleep pressure during wakefulness; blocking these receptors plausibly sustains alertness while attenuating sleep-homeostatic slow-wave activity.

CYP1A2 genotype and exposure

  • rs762551 AC is plausibly associated with intermediate, or relatively slower-than-AA, caffeine clearance. The A allele is linked to greater CYP1A2 inducibility, especially under inducing conditions, rather than a fixed clearance rate.
  • Slower clearance can extend caffeine’s concentration-time profile, but AC does not provide a validated individual half-life, AUC, or clearance estimate. Smoking can induce CYP1A2 and increase clearance, while oral contraceptives inhibit it and reduce clearance; habitual intake and other factors also matter.

Bottom line

  • Caffeine can delay sleep onset, reduce deep sleep, and fragment sleep, especially at higher doses later in the day. AC genotype may contribute to prolonged exposure, but it should not be used alone to predict personal caffeine sensitivity or timing.

References

  1. The Effect of Consuming Caffeine Before Late Afternoon/Evening ... — pmc.ncbi.nlm.nih.gov ↗
  2. Adenosine, caffeine, and sleep–wake regulation: state of the ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  3. Clinical and Physiological Correlates of Caffeine and ... - PMC - NIHpmc.ncbi.nlm.nih.gov › articles › PMC3077349 — pmc.ncbi.nlm.nih.gov ↗
  4. Age- and dose-specific effects of caffeine on sleep ... - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  5. Dose and timing effects of caffeine on subsequent sleep — academic.oup.com ↗
  6. Caffeine - StatPearls - NCBI Bookshelf - NIH — ncbi.nlm.nih.gov ↗
  7. Journal of Clinical Sleep Medicine — jcsm.aasm.org ↗
  8. The impact of genetic polymorphisms on CYP1A2 activity in humans: a systematic review and meta-analysis - The Pharmacogenomics Journal — nature.com ↗
  9. Impact of Genetic Variability on Physiological Responses to Caffeine in Humans: A Systematic Review — mdpi.com ↗
  10. Exploring the relationship between caffeine metabolism ... — link.springer.com ↗
  11. Pharmacokinetic and Pharmacodynamic Effects of Caffeine — efsa.europa.eu ↗
  12. Impact of CYP1A2 Genotypes on the Ergogenic Effects and ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  13. Unraveling the complexities of caffeine: metabolism, genetics ... — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible9 sourcesCan menopausal vasomotor symptoms trigger nighttime awakenings and reduce sleep continuity?→Plausible8 sourcesCan low iron stores and the BTBD9 rs3923809 AG genotype increase restless legs symptoms and related sleep movements?→